<DOC>
	<DOCNO>NCT02329600</DOCNO>
	<brief_summary>The study include forty individual divide 3 group . 10 control subject , 15 oral lichen planus ( OLP ) patient treat topical corticosteroid 15 oral lichen planus ( OLP ) patient treat topical corticosteroid green tea tablet .</brief_summary>
	<brief_title>Evaluation Green Tea Antioxidant Agent Management Oral Lichen Planus</brief_title>
	<detailed_description>This study include forty individual divide 3 group . Group A ; 10 systemically healthy control subject receive medication . Group B ; 15 Patients previously diagnose OLP present acute exacerbation treat topical corticosteroid ; Triamcinolone acetonide ( Kenalog orabase : Bristol-Myers , Squibb , Spain ) apply topically 4 time day i.e . follow meal bed time one month . Group C ; 15 Patients previously diagnose OLP present acute exacerbation treat topical corticosteroid ; Triamcinolone acetonide ( Kenalog orabase : Bristol-Myers , Squibb , Spain ) apply topically 4 time day i.e . follow meal bed time one month addition green tea tablet 200 mg ( Green tea extract 5:1 , El Obour For Modern Pharmaceutical Industries ) one tablet day also one month .</detailed_description>
	<mesh_term>Lichen Planus , Oral</mesh_term>
	<mesh_term>Lichen Planus</mesh_term>
	<mesh_term>Triamcinolone hexacetonide</mesh_term>
	<mesh_term>Triamcinolone Acetonide</mesh_term>
	<mesh_term>Triamcinolone</mesh_term>
	<mesh_term>Triamcinolone diacetate</mesh_term>
	<mesh_term>Antioxidants</mesh_term>
	<mesh_term>Benzocaine</mesh_term>
	<criteria>Patients present painful oral lichen planus lesion Free visible oral lesion oral lichen planus Free systemic diseases Topical treatment systemic therapy OLP one month start study Pregnant breast feed woman Smokers Use corticosteroid immunosuppressive drug</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>68 Years</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>